Determination of tamoxifen and its metabolites in the endometrial tissue of long-term treated women

European Journal of Cancer

Volumn 36, Issue SUPPL. 4, 2000, Pages 88-89

  Giorda, G ^a   Franceschi, L ^b   Crivellari, D ^a   Magri, M D ^a   Veronesi, A ^a   Scarabelli, C ^a   Furlanut, M ^b  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

Author keywords

Endometrium; Tamoxifen; Tissue distribution

Indexed keywords

4 HYDROXYTAMOXIFEN; DRUG METABOLITE; ESTROGEN RECEPTOR; NORTAMOXIFEN; TAMOXIFEN; TAMOXIFEN DERIVATIVE;

ARTICLE; BREAST CANCER; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG TISSUE LEVEL; FEMALE; HUMAN; HUMAN TISSUE; HYSTEROSCOPY; MASS SPECTROMETRY; PRIORITY JOURNAL; RECEPTOR BINDING; TISSUE DISTRIBUTION; TISSUE SPECIFICITY;

EID: 0033736526     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0959-8049(00)00242-2     Document Type: Article

References (2)

1. Quantitative measurement of 4-hydroxy tamoxifen in human plasma and mammary tumors by combined gas chromatography/negative chemical ionization mass spectrometry
2. Distribution of tamoxifen and its metabolites in rat and human tissues during steady-state treatment